Molecule

Immunoglobulin Lambda Light Chain (IGLV1-44/IGLV1-40)

Monoclonal protein produced by clonal plasma cells — near-universal lambda restriction

Expression change
Monoclonal overproduction
Evidence level
established

Role in pathogenesis

Over 95% of POEMS cases have lambda light chain restriction. The variable regions are highly restricted to IGLV1-44*01 (~80%) and IGLV1-40*01 (~20%), with conserved stereotypic amino acid changes in CDR1 and FR2 regions. This extreme restriction, unique among plasma cell disorders, suggests antigen-driven selection. The monoclonal protein itself may contribute to neuropathy through direct nerve damage or immune-mediated mechanisms.

Sources (3)

DetailsAbe D et al. (2008) Restrictive usage of monoclonal immunoglobulin lambda light chain germline in POEMS syndromeDOI
DetailsIsshiki T et al. (2022) Unraveling unique features of plasma cell clones in POEMS syndrome with single-cell analysisDOI
DetailsAbe D et al. (2020) Immunoglobulin variable domain high-throughput sequencing reveals specific novel mutational patterns in POEMS syndromeDOI